Over 400 firms, including Cipla, Airtel & Tata Steel, to unveil Q4 results this week. Track key announcements and dividend…
Metropolis Healthcare sets March 20 as record date for 3:1 bonus shares; check allotment date!
Track key corporate actions, dividends, rights issues, and crucial economic data releases in Indian markets this week—stay updated now!
Discover 5 major healthcare changes expected in Budget 2026, including cheaper meds and new tax rules—see what industry experts recommend.
Strong growth in medical testing has benefited leading pathological laboratory chains. And two leading chains have recently declared bonus issues.…
Discover Nuvama’s top healthcare stock picks for FY26 as hospitals and diagnostics rebound; see which stocks to watch now!
The idea is to build a string-of-pearls across North. We will keep looking for the right acquisition opportunities in other…
Cervical cancer remains a major health challenge for Indian women, despite being preventable through early screening and vaccination.
According to experts, the Antinuclear Antibody (ANA) test is recognized as one of the gold standard screening tools for diagnosing…
It covers a wide range of specialties including haematology, microbiology, molecular biology, special chemistry, immunology, histology and cytology, the diagnostics…
We are now clearly seeing an opportunity to penetrate into tier two, tier three cities and maybe even go into…
Metropolis Healthcare posted revenue from operations at Rs 331.00 crore, up 17.1 per cent as against Rs 282.55 reported during…
According to the International Diabetes Federation (IDF) and the World Health Organization (WHO), by 2030, 1 in 9 people, or…
This newly launched diagnostic laboratory has the capacity to process more than 200+ samples per day, with quick turnaround times…
This AI-powered Allergy Component Testing is now available at all Metropolis laboratories, patient collection facilities, and through home collection services…
Surendran will be joining Metropolis Healthcare Limited as CEO, effective from 2nd January 2023.
Digital developments driving growth for home COVID-19 have been responsible for the exponential growth of home diagnostics.
Worldwide, the estimated incidence of Down Syndrome is between 1 in 1,000 to 1 in 1,100 live births. In India…